Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

The HR protein helps hair grow by blocking a hair growth inhibitor, aiding in hair follicle regeneration.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Mutant mice help researchers understand hair growth and related genetic factors.

A new gene, JMJD1C, may affect testosterone levels in men.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Wnt signaling is crucial for skin and hair development and its disruption can cause skin tumors.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Early hair loss may indicate prostate issues.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.